Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson's Disease
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05766813 |
|
Recruitment Status :
Recruiting
First Posted : March 13, 2023
Last Update Posted : October 24, 2023
|
Sponsor:
Intra-Cellular Therapies, Inc.
Information provided by (Responsible Party):
Intra-Cellular Therapies, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | February 2025 |
| Estimated Study Completion Date : | February 2025 |